Able Innovations
Able Innovations is solving the painful and labour-intensive process of patient transfers by developing innovative robotic technology that enables effortless, contactless, single caregiver, safe and dignified transfers. Their DELTA Platform™, is capable of automated transfers of supine individuals who need to be moved laterally (ex. Bed to stretcher, imaging table) in healthcare facilities. With our front line staff reaching a breaking point, and facilities struggling to balance budgets- the DELTA Platform™ will result in safer working conditions for staff, and more sustainable operations for facilities as they will be able to do more with less.
Presenter: Jayiesh Singh, Chief Executive Officer
Read More
AceAge
AceAge, founded in 2015, is a revenue-generating healthcare technology company based in Burlington, ON, creating an in-home medication dispenser Karie to help people age in place and improve health outcomes. AceAge has sold over 10,000 Karie devices (contracts valued over C$28 million over 5 years), for distribution across Canada, the Netherlands, and Norway. AceAge is raising Series A capital to expand into the US, Asia and other countries across Europe. Implementation includes pharmacy integration, certification and regulatory compliance.
Presenter: Spencer Waugh, CEO
Read More
AltumView Systems
AltumView is a Vancouver AI company founded in 2016. It develops a smart sensor for applications such as senior care, security, and telehealth. The sensor monitors the activity of people such as seniors, collect health statistics, and notify caregivers when emergencies are detected, while preserving privacy. It has been in the markets of Canada, Japan, China, and Taiwan for one year. The second-generation sensor will be released in early 2021, which recently won the CES 2021 Innovation Award Honoree. The company has raised several rounds of angel funds, and is seeking new capital to scale up manufacturing, marketing, and R&D.
Presenter: Jie Liang, President and CEO
Read More
Curiato
Curiato is a digital health platform that is leveraging biosensing and AI to deliver patient data and insights directly from the surface of the bed to power an ecosystem of applications such as pressure injuries, heart failure, infectious disease, burns, patient safety and more. One device, multiple clinical software applications. Curiato is post revenue with successful clinical pilots, publications and Health Canada licensed. Curiatio is raising Series A capital to support US market entry, sales & marketing, and creation of additional clinical software applications.
Presenter: Moazam Khan, Co-Founder & CEO
Read More
Curovate
Curovate is revolutionizing physiotherapy by making it accessible, affordable and improving patient outcomes and adherence. Physiotherapy following orthopaedic surgery has major barriers to access due to the high cost and low adherence. This results in 80% of people not doing their rehabilitation after surgery. Curovate offers a subscription-based mobile app for rehabilitation following a total knee replacement, total hip replacement and an anterior cruciate ligament (ACL) surgery available through the Apple and Google App Stores. We are at the Seed stage seeking an investment of $200,000. This investment would be used for advertising, business to business engagement and software development.
Hear more from this company during the Early Technology Showcase.
Presenter: Nirtal Shah, CEO
Read More
Nightingale.ai
Nightingale.ai is in development of a computer vision-based mobile application for end-to-end automation of physiotherapy management of patients post total hip and knee replacement. This self-assessment and treatment planning tool enable remote personalized care in a cost-effective manner. The company is currently in pre-seed stage. The proceeds from seed financing will be used on creating the prototype of the first-of-its-kind computer vision-based functional tests and treatment planning, conducting pre-clinical trials, and covering essential developer compensation.
Hear more from this company during the Early Technology Showcase.
Presenter: Sameer Chunara, Co-founder and CEO
Read More
PROTXX
PROTXX enhances care, outcomes, and healthcare economics for patients living with neuro-disruptive (e.g. concussion, stroke) and neuro-degenerative (e.g. multiple sclerosis, Parkinson’s disease) medical conditions. Our precision health platform integrates innovations in non-invasive wearable physiological sensors and machine learning classification of neurosensory and neuromotor impairments, replacing complex clinical equipment and time-consuming tests with easier-to-use, lower-cost, in-clinic and remote precision patient assessments. At the core of the PROTXX platform is the company’s “phybrata” sensor, a tiny, non-invasive device worn behind the ear that is able to classify, quantify, and monitor impairments to the major neurophysiological systems in the body.
Presenter: John Ralston, CEO and Founder
Read More
Steadiwear
Steadiwear develops battery-free gloves that stabilizes hand tremors in Parkinson’s disease & Essential tremor using technology was inspired by leading-edge earthquake dampers used in buildings. We are raising seed funding for clinical trial & health economics studies, manufacturing, and sales and marketing.
Presenter: Mark Elias, CEO
Read More
VitalTracer
VitalTracer is a start-up whose focus is on healthcare in the domain of personalized medicine. We aim to create a platform for those who need to improve or manage health with a convenient and non-invasive solution. VitalTracer has raised about 1 million in non-dilutive financing and is currently boot-strapping. We will open our seed round in summer 2021 which will cover our expenses of Research and Development, Regulatory clearance for Health Canada and FDA, manufacturing and clinical validation.
Presenter: Azadeh Dastmalchi, CEO
Read More
